Absci Corp (ABSI)

May 20, 2025, 8:00 AM EDT - 16 days ago

Absci to Participate in Upcoming Investor Conferences

May 13, 2025, 10:45 PM EDT - 23 days ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 23 days ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:01 PM EDT - 23 days ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Apr 14, 2025, 4:05 PM EDT - 7 weeks ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 3, 2025, 3:15 PM EDT - 2 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Mar 19, 2025, 8:15 AM EDT - 2 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Mar 18, 2025, 7:37 PM EDT - 2 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 2 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 4:05 PM EST - 3 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:00 PM EST - 3 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 8:00 AM EST - 3 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Feb 18, 2025, 8:00 AM EST - 3 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Jan 22, 2025, 1:22 PM EST - 4 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Jan 22, 2025, 8:00 AM EST - 4 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 13, 2025, 2:05 AM EST - 5 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Jan 10, 2025, 7:30 AM EST - 5 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 5 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 6, 2025, 8:00 AM EST - 5 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Nov 12, 2024, 10:01 AM EST - 7 months ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:30 AM EST - 7 months ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 7, 2024, 8:00 AM EST - 7 months ago

Absci to Host R&D Day on December 12, 2024

Oct 15, 2024, 8:00 AM EDT - 8 months ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 3, 2024, 12:36 PM EDT - 8 months ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Aug 16, 2024, 11:50 PM EDT - 10 months ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 10 months ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 8:00 AM EDT - 10 months ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Jul 28, 2024, 1:24 AM EDT - 11 months ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 10, 2024, 8:00 AM EDT - 11 months ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 1, 2024, 4:01 PM EST - 1 year ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 27, 2024, 10:20 PM EST - 1 year ago

Absci Announces Pricing of Public Offering of Common Stock

Feb 27, 2024, 4:01 PM EST - 1 year ago

Absci Announces Proposed Public Offering of Common Stock

Feb 21, 2024, 7:30 AM EST - 1 year ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Jan 10, 2024, 7:30 AM EST - 1 year ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 3, 2024, 8:00 AM EST - 1 year ago

Absci to Participate in the 26th Annual Needham Growth Conference

Dec 28, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 20, 2023, 7:30 AM EST - 1 year ago

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Dec 4, 2023, 7:30 AM EST - 1 year ago

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Dec 3, 2023, 1:28 AM EST - 1 year ago

AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT

AZN

Nov 15, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 14, 2023, 4:05 PM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

Nov 14, 2023, 2:16 AM EST - 1 year ago

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

Sep 21, 2023, 8:00 AM EDT - 1 year ago

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

Sep 6, 2023, 8:00 AM EDT - 1 year ago

Absci to Host R&D Day on October 4, 2023

Sep 5, 2023, 10:40 AM EDT - 1 year ago

Biotech company Absci lays off 30 employees, about 15% of staff

Aug 14, 2023, 8:02 AM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results